The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Self-citationA cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Self-citationNOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
Estey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Self-citationHope, K. J., Jin, L., & Dick, J. E. (2004) · Nature Immunology · doi:10.1038/ni1080 · Cited by 968
Self-citationIshikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1350 · Cited by 909
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
Bhatia, M., Wang, J. C. Y., Kapp, U., Bonnet, D., & Dick, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5320 · Cited by 850
Self-citationJordan, C., Upchurch, D., Szilvassy, S., Guzman, M., Howard, D., Pettigrew, A., Meyerrose, T., Rossi, R., Grimes, B., Rizzieri, D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401903 · Cited by 821
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Cancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 615
Self-citationReceptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
Miyajima, A., Mui, A., Ogorochi, T., & Sakamaki, K. (1993) · Blood · doi:10.1182/blood.v82.7.1960.1960 · Cited by 416
van Rhenen, A., Feller, N., Kelder, A., Westra, A. H., Rombouts, E., Zweegman, S., van der Pol, M. A., Waisfisz, Q., Ossenkoppele, G. J., & Schuurhuis, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0468 · Cited by 375
Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., et al. (2008) · Blood · doi:10.1182/blood-2007-10-118331 · Cited by 373
Testa, U., Riccioni, R., Militi, S., Coccia, E., Stellacci, E., Samoggia, P., Latagliata, R., Mariani, G., Rossini, A., Battistini, A., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0852 · Cited by 296
Guan, Y., Gerhard, B., & Hogge, D. E. (2003) · Blood · doi:10.1182/blood-2002-10-3062 · Cited by 293
Mazurier, F., Doedens, M., Gan, O. I., & Dick, J. E. (2003) · Nature Medicine · doi:10.1038/nm886 · Cited by 281
Self-citationInterleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Muñoz, L., Nomdedeu, J. F., López, O., Carnicer, M. J., Bellido, M., Aventin, A. M., Brunet, S., & Sierra, J. (2001) · PubMed · Cited by 269
Pearce, D. J., Taussig, D., Zibara, K., Smith, L.-L., Ridler, C. M., Preudhomme, C., Young, B. D., Rohatiner, A. Z., Lister, T. A., & Bonnet, D. (2006) · Blood · doi:10.1182/blood-2005-06-2325 · Cited by 234
Nishinakamura, R., Miyajima, A., Mee, P., Tybulewicz, V., & Murray, R. (1996) · Blood · doi:10.1182/blood.v88.7.2458.bloodjournal8872458 · Cited by 208
Lock, R. B., Liem, N., Farnsworth, M. L., Milross, C. G., Xue, C., Tajbakhsh, M., Haber, M., Norris, M. D., Marshall, G. M., & Rice, A. M. (2002) · Blood · doi:10.1182/blood.v99.11.4100 · Cited by 208
Self-citationMiyauchi, J., Kelleher, C., Yang, Y., Wong, G., Clark, S., Minden, M., Minkin, S., & McCulloch, E. (1987) · Blood · doi:10.1182/blood.v70.3.657.657 · Cited by 208
Bagley, C. J., Woodcock, J. M., Stomski, F. C., & Lopez, A. F. (1997) · Blood · doi:10.1182/blood.v89.5.1471 · Cited by 180
Self-citationTanaka, T., Kitamura, F., Nagasaka, Y., Kuida, K., Suwa, H., & Miyasaka, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1103 · Cited by 174
McKenzie, J. L., Gan, O. I., Doedens, M., Wang, J. C. Y., & Dick, J. E. (2006) · Nature Immunology · doi:10.1038/ni1393 · Cited by 159
Self-citationExpression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells
Hauswirth, A. W., Florian, S., Printz, D., Sotlar, K., Krauth, M. ‐., Fritsch, G., Schernthaner, G. ‐., Wacheck, V., Selzer, E., Sperr, W. R., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01746.x · Cited by 158
Vellenga, E., Ostapovicz, D., O'Rourke, B. P., & Griffin, J. D. (1987) · PubMed · Cited by 157
Chemotherapy and Cancer Stem Cells
Rich, J. N., & Bao, S. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.09.011 · Cited by 152
Florian, S., Sonneck, K., Hauswirth, A. W., Krauth, M., Schernthaner, G.-H., Sperr, W. R., & Valent, P. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500272507 · Cited by 151
McKenzie, J. L., Gan, O. I., Doedens, M., & Dick, J. E. (2005) · Blood · doi:10.1182/blood-2005-03-1081 · Cited by 147
Self-citationInterleukin-3 receptor in acute leukemia
Testa, U., Riccioni, R., Diverio, D., Rossini, A., Coco, F. L., & Peschle, C. (2003) · Leukemia · doi:10.1038/sj.leu.2403224 · Cited by 131
Budel, L., Touw, I. P., Delwel, R., et al. (1989) · Blood · doi:10.1182/blood.v74.2.565.565 · Cited by 128
Sun, Q., Woodcock, J. M., Rapoport, A. P., Stomski, F. C., Korpelainen, E., Bagley, C., Goodall, G. J., Smith, W., Gamble, J. R., Vadas, M., et al. (1996) · Blood · doi:10.1182/blood.v87.1.83.83 · Cited by 107
Self-citationGrowth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, M. A., Powell, J. A., Barry, E. F., Stomski, F. C., McClure, B. J., Ramshaw, H. S., Felquer, F. A., Dottore, M., Thomas, D., To, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600948 · Cited by 89
Self-citationGuthridge, M. A., Barry, E. F., Felquer, F. A., McClure, B. J., Stomski, F. C., Ramshaw, H. S., & Lopez, A. F. (2003) · Blood · doi:10.1182/blood-2003-06-1999 · Cited by 79
Self-citationGraf, M., Hecht, K., Reif, S., et al. (2004) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2003.00184.x · Cited by 72
Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm.
Wang, J. C. Y. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.10.005 · Cited by 70
Yalçıntepe, L., Frankel, A. E., & Hogge, D. E. (2006) · Blood · doi:10.1182/blood-2006-04-013813 · Cited by 52
Guan, Y., & Hogge, D. E. (2000) · Leukemia · doi:10.1038/sj.leu.2401975 · Cited by 50
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Fujii, H., Trudeau, J. D., Teachey, D. T., Fish, J. D., Grupp, S. A., Schultz, K. R., & Reid, G. S. D. (2006) · Blood · doi:10.1182/blood-2006-02-002055 · Cited by 41
Human leukaemic stem cells: a novel target of therapy
Sperr, W. R., Hauswirth, A. W., Florian, S., Öhler, L., Geissler, K. H., & Valent, P. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.0960-135x.2004.01368.x · Cited by 34
Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias
Morgan, M. A., & Reuter, C. W. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0051-7 · Cited by 33
Riccioni, R., Rossini, A., Calabrò, L., Diverio, D., Pasquini, L., Lo‐Coco, F., Peschle, C., & Testa, U. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/104281090310001646031 · Cited by 19
Tsuzuki, M., Ezaki, K., Maruyama, F., Ino, T., Kojima, H., Okamoto, M., Yamaguchi, T., Nomura, T., Miyazaki, H., Wakita, M., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400870 · Cited by 17
Novel agents in acute myeloid leukemia.
Aribi, A. M., Ravandi, F., & Giles, F. (2006) · PubMed · Cited by 11
Cited by
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Stem cell concepts renew cancer research
Dick, J. E. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,010
Self-citationTumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
Cancer stem cell definitions and terminology: the devil is in the details
Valent, P., Bonnet, D., De Maria, R., Lapidot, T., Copland, M., Melo, J. V., Chomienne, C., Ishikawa, F., Schuringa, J. J., Stassi, G., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3368 · Cited by 692
Metadata
- Authors
- Jin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., Gearing, D. P., Vairo, G., Lopez, A. F., Dick, J. E., & Lock, R. B.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 5
- Issue
- 1
- Pages
- 31-42
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W2087762900
- Cited by
- 522
- References
- 45
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.